Science for a better life

Explore Your Topic

Bayer completes biggest acquisition in its history

Divisions Of China

Bayer Helps to Build Consumer Health Product-and-Solution Platform

Bayer Announces Signing of Strategic Framework Agreement with JD Pharmacy

Bayer Contributes to the “Fight for Targeted Poverty Alleviation”

First-in-class glucokinase activator (GKA) HuaTangNing approved in China

Bayer completes sale of its Environmental Science Professional business to Cinven

Bayer and Hua Medicine announce strategic partnership for diabetes treatment

2022-10-05

Bayer completes sale of its Environmental Science Professional business to Cinven

2021-11-24

Bayer Coordinated Vulnerability Disclosure Statement

2021-11-10

Bayer Embraces Rewarding Opportunities at 4th CIIE

2021-08-21

Bayer starts Phase III clinical development program OASIS with Elinzanetant

Explore Our Businesses

We address some of the world's most pressing global challenges and continue to develop new solutions. The population is constantly growing and its age is increasing. That is why it needs better medicines and high-quality food in sufficient quantities. Learn more about it here.